Breaking News Instant updates and real-time market news.

KRTX

Karuna Therapeutics

$64.48

-2.06 (-3.10%)

07:41
12/12/19
12/12
07:41
12/12/19
07:41

Karuna Therapeutics initiated with an Outperform at William Blair

William Blair analyst Myles Minter initiated coverage of Karuna Therapeutics with an Outperform rating.

KRTX Karuna Therapeutics
$64.48

-2.06 (-3.10%)

07/23/19
WEDB
07/23/19
INITIATION
Target $38
WEDB
Outperform
Karuna Therapeutics initiated with an Outperform at Wedbush
Wedbush analyst Liana Moussatos started coverage of Karuna Therapeutics with an Outperform rating and a $38 price target. The analyst considers Karuna Therapeutics to be an opportunity to invest in a breakthrough oral treatment for symptoms and cognitive impairment associated with schizophrenia and Alzheimer's disease as well as pain. Due to millions of schizophrenia and Alzheimer's disease patients and low compliance for current "dirty" drugs available for psychosis and nothing approved for negative symptoms or cognitive impairment, Moussatos sees blockbuster sales potential for KarXT. Starting with U.S. launch in 2023, she estimates KarXT could achieve over $1B in gross peak annual sales in 2027 and more than $4B in 2030.
11/18/19
GSCO
11/18/19
NO CHANGE
Target $109
GSCO
Buy
Karuna Therapeutics price target raised to $109 from $35 at Goldman Sachs
Goldman Sachs analyst Salveen Richter raised his view on the odds of success of KarXT for the treatment of acute psychosis in patients with schizophrenia to 60% from 15% after Karuna Therapeutics announced results from its Phase 2 clinical trial of the drug. In his view, the strong signal of efficacy coupled with the drug's tolerability profile support use of KarXT in schizophrenia psychosis and have a positive read-through to the pipeline for Alzheimer's disease psychosis, Richter tells investors. He keeps a Buy rating on Karuna shares and raised his price target on the stock to $109 from $35.
11/18/19
SBSH
11/18/19
NO CHANGE
Target $115
SBSH
Buy
Karuna Therapeutics price target raised to $115 from $28 at Citi
Citi analyst Mohit Bansal said the phase 2 data reported by Karuna Therapeutics for KarXT appear better than expected, better than current anti-psychotics, and could be "paradigm changing." The drug's "benign" safety lead him to see the potential for use as a front line agent as well, leading the analyst to raise his peak unadjusted sales estimate in schizophrenia to $4.7B from $2.3B. Given the higher peak sales potential, and higher odds assigned for the drug's approval, Bansal raised his price target for Karuna shares to $115 from $28. The analyst, who thinks there is more upside in the stock despite today's move, keeps a Buy rating on Karuna shares, which are up $64.52, or 365%, to $82.20.
11/21/19
WEDB
11/21/19
NO CHANGE
Target $134
WEDB
Outperform
Karuna Therapeutics price target raised to $134 from $38 at Wedbush
Wedbush analyst Liana Moussatos raised her price target for Karuna Therapeutics to $134 from $38 and maintained an Outperform rating after the company reported positive topline results from its Phase 2 trial of KarXT for the treatment of acute psychosis in patients with schizophrenia, saying KarXT met the primary endpoint of mean reduction in total PANSS score compared to placebo and demonstrated statistically significant reductions in key secondary endpoints of PANSS-Positive and PANSS-Negative scores along with tolerable side effects. In a research note to investors, Moussatos says that due to KarXT likely becoming a blockbuster, she believes Karuna is likely to become an acquisition target in 2020.

TODAY'S FREE FLY STORIES

ABT

Abbott

$89.76

0.76 (0.85%)

, BKR

Baker Hughes

$22.72

-0.9 (-3.81%)

20:25
01/21/20
01/21
20:25
01/21/20
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$89.76

0.76 (0.85%)

BKR

Baker Hughes

$22.72

-0.9 (-3.81%)

ALLY

Ally Financial

$30.25

-0.19 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Mar

MDT

Medtronic

$120.30

1.32 (1.11%)

20:03
01/21/20
01/21
20:03
01/21/20
20:03
Recommendations
Medtronic analyst commentary  »

Medtronic price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 18

    Feb

CNC

Centene

$65.48

0.96 (1.49%)

, WCG

WellCare

$340.52

3.55 (1.05%)

19:49
01/21/20
01/21
19:49
01/21/20
19:49
Hot Stocks
WellCare, Centene satisfy merger requirements »

Centene (CNC) and…

CNC

Centene

$65.48

0.96 (1.49%)

WCG

WellCare

$340.52

3.55 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

  • 13

    Feb

AAPL

Apple

$316.39

-2.27 (-0.71%)

, HNHPF

Hon Hai Precision

$0.00

(0.00%)

19:17
01/21/20
01/21
19:17
01/21/20
19:17
Periodicals
Apple suppliers to start making new low-cost iPhone in February, Bloomberg says »

Apple (AAPL) suppliers…

AAPL

Apple

$316.39

-2.27 (-0.71%)

HNHPF

Hon Hai Precision

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

EFC

Ellington Financial

$18.85

0.13 (0.69%)

19:12
01/21/20
01/21
19:12
01/21/20
19:12
Syndicate
Ellington Financial 4.6M share Spot Secondary priced at $18.29 »

Morgan Stanley, Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

MRVSY

Minerva SA

$0.00

(0.00%)

18:59
01/21/20
01/21
18:59
01/21/20
18:59
Downgrade
Minerva SA rating change  »

Minerva SA downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRPBF

Grupo Lala

$0.00

(0.00%)

18:57
01/21/20
01/21
18:57
01/21/20
18:57
Downgrade
Grupo Lala rating change  »

Grupo Lala downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCU

Compania Cervecerias

$19.00

-0.33 (-1.71%)

18:53
01/21/20
01/21
18:53
01/21/20
18:53
Downgrade
Compania Cervecerias rating change  »

Compania Cervecerias…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRPBF

Grupo Lala

$0.00

(0.00%)

18:50
01/21/20
01/21
18:50
01/21/20
18:50
Upgrade
Grupo Lala rating change  »

Grupo Lala upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPAGF

Gruma

$0.00

(0.00%)

18:48
01/21/20
01/21
18:48
01/21/20
18:48
Upgrade
Gruma rating change  »

Gruma upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOF

Coca-Cola Femsa

$62.52

0.41 (0.66%)

18:47
01/21/20
01/21
18:47
01/21/20
18:47
Upgrade
Coca-Cola Femsa rating change  »

Coca-Cola Femsa upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGI

Logitech

$47.77

1.2 (2.58%)

18:46
01/21/20
01/21
18:46
01/21/20
18:46
Hot Stocks
Logitech CEO: We're growing all three of our businesses at a healthy clip »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

NAVI

Navient

$13.86

-0.01 (-0.07%)

, IBM

IBM

$139.15

0.84 (0.61%)

18:44
01/21/20
01/21
18:44
01/21/20
18:44
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

NAVI

Navient

$13.86

-0.01 (-0.07%)

IBM

IBM

$139.15

0.84 (0.61%)

COF

Capital One

$102.29

-1.85 (-1.78%)

FBK

FB Financial

$38.20

-0.66 (-1.70%)

NFLX

Netflix

$338.24

-1.32 (-0.39%)

MNLO

Menlo Therapeutics

$6.48

-0.17 (-2.56%)

CIT

CIT Group

$45.23

-1.17 (-2.52%)

SKT

Tanger Factory

$15.93

0.56 (3.64%)

ETN

Eaton

$94.51

-1.19 (-1.24%)

SUPN

Supernus

$24.70

0.26 (1.06%)

ZION

Zions Bancorp

$49.93

-0.81 (-1.60%)

IBKR

Interactive Brokers

$50.89

0.7 (1.39%)

AMTD

TD Ameritrade

$50.76

0.25 (0.49%)

FULT

Fulton Financial

$17.26

-0.07 (-0.40%)

UAL

United Airlines

$85.84

-3.84 (-4.28%)

ADAP

Adaptimmune

$4.14

-0.38 (-8.41%)

BPMC

Blueprint Medicines

$79.69

-1.46 (-1.80%)

ELAN

Elanco

$30.64

0.65 (2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 21

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 28

    Jan

  • 04

    Feb

  • 06

    Feb

  • 06

    Feb

  • 14

    Feb

  • 19

    Feb

  • 26

    Feb

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

SUPN

Supernus

$24.70

0.26 (1.06%)

18:35
01/21/20
01/21
18:35
01/21/20
18:35
Hot Stocks
Supernus: FDA accepts for review NDA for SPN-812 »

Supernus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$338.24

-1.32 (-0.39%)

18:31
01/21/20
01/21
18:31
01/21/20
18:31
Hot Stocks
Netflix says doesn't want to 'exploit' users with advertising »

Says mobile-only plans in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

COST

Costco

$313.28

8.6 (2.82%)

18:25
01/21/20
01/21
18:25
01/21/20
18:25
Hot Stocks
Costco CEO: We're a volume company, not a margin company »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 05

    Mar

NFLX

Netflix

$338.24

-1.32 (-0.39%)

18:24
01/21/20
01/21
18:24
01/21/20
18:24
Hot Stocks
Netflix says plans to increase content spending across the board »

Says plans to increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

PBR

Petrobras

$14.76

-0.41 (-2.70%)

18:23
01/21/20
01/21
18:23
01/21/20
18:23
Hot Stocks
Petrobras says CARF issued 'unfavorable' decision on tax proceeding »

Petrobras said that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBI

First Midwest

$21.58

-0.725 (-3.25%)

18:15
01/21/20
01/21
18:15
01/21/20
18:15
Earnings
First Midwest reports Q4 EPS 51c, consensus 50c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

NFLX

Netflix

$338.24

-1.32 (-0.39%)

, DIS

Disney

$143.53

-0.72 (-0.50%)

18:14
01/21/20
01/21
18:14
01/21/20
18:14
Hot Stocks
Netflix says Oscar-nominated original films 'very popular' with users as well »

Netflix (NFLX) says…

NFLX

Netflix

$338.24

-1.32 (-0.39%)

DIS

Disney

$143.53

-0.72 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 04

    Feb

MDT

Medtronic

$120.30

1.32 (1.11%)

18:12
01/21/20
01/21
18:12
01/21/20
18:12
Hot Stocks
Medtronic: Trial shows 'superior' back pain relief with DTM SCS »

Medtronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

NFLX

Netflix

$338.24

-1.32 (-0.39%)

, DIS

Disney

$143.53

-0.72 (-0.50%)

18:07
01/21/20
01/21
18:07
01/21/20
18:07
Hot Stocks
Netflix says seasonality from Q1 to Q2 likely to be 'more balanced' »

Netflix (NFLX) says Q1…

NFLX

Netflix

$338.24

-1.32 (-0.39%)

DIS

Disney

$143.53

-0.72 (-0.50%)

GOOG

Alphabet

$1,484.92

4.64 (0.31%)

GOOGL

Alphabet Class A

$1,482.70

3.58 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 03

    Feb

  • 03

    Feb

  • 04

    Feb

  • 10

    Feb

BFC

Bank First National

$66.28

-0.62 (-0.93%)

18:06
01/21/20
01/21
18:06
01/21/20
18:06
Earnings
Bank First National reports Q4 EPS $1.05, consensus $1.04 »

Net interest margin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$149.01

0.805 (0.54%)

18:01
01/21/20
01/21
18:01
01/21/20
18:01
Periodicals
Spotify's new feature lets influencers post Stories to their playlists, TC says »

Tech Crunch's Sarah…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

HCM

Hutchison China MediTech

$29.56

0.135 (0.46%)

17:58
01/21/20
01/21
17:58
01/21/20
17:58
Syndicate
Hutchison China MediTech files to sell $110M of ADSs »

BofA Securities, Goldman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.